From: Drug utilization in neonatal setting of Pakistan: focus on unlicensed and off label drug prescribing
Variables | n (%) HMC | n (%) KTH | n (%) LRH | n (%) NWGH | Total |
---|---|---|---|---|---|
Gender | |||||
Male | 253 (19.46) | 232 (17.85) | 236 (18.15) | 163 (12.54) | 884 (68.00) |
Female | 97 (7.46) | 123 (9.46) | 119 (9.15) | 77 (5.92) | 416 (32.00) |
Total | 350 (26.92) | 355 (27.31) | 355 (27.31) | 240 (18.46) | 1300 (100) |
Gestational age | |||||
Term Infants | 272 (20.92) | 256 (19.69) | 294 (22.62) | 207 (15.92) | 1029 (79.15) |
Preterm infants | 78 (6.00) | 99 (7.62) | 61 (4.69) | 33 (2.54) | 271 (20.85) |
Total | 350 (26.92) | 355 (27.31) | 355 (27.31) | 240 (18.46) | 1300 (100.00) |
Age (Days) | |||||
≤ 7 days old | 275 (21.15) | 280 (21.54) | 309 (23.77) | 110 (8.46) | 974 (74.92) |
8 to 14 days old | 25 (1.92) | 35 (2.69) | 41 (3.15) | 42 (3.23) | 143 (11.00) |
15 to 21 days old | 20 (1.54) | 12 (0.92) | 5 (0.38) | 9 (0.69) | 46 (3.54) |
22 to 30 days | 30 (2.31) | 28 (2.15) | – | 79 (6.08) | 137 (10.54) |
Total | 350 (26.92) | 355 (27.31) | 355 (27.31) | 240 (18.46) | 1300 (100) |
Mean ± S.D | 0.20 ± 0.327 | 0.21 ± 0.36 | 0.10 ± 0.111 | 0.69 ± 1.20 | 0.27 ± 0.613 |
Range | 0.97 (0.03–1.00) | 2.97 (0.03–3.00) | 0.47 (0.03–0.05) | 0.97 (0.03–1.00) | 0.97 (0.03–1.00) |
Prescribed drugs | |||||
1 to 3 drugs | 255 (19.62) | 326 (25.08) | 257 (19.77) | 148 (11.38) | 986 (75.85) |
4 to 6 drugs | 93 (7.15) | 21 (1.62) | 94 (7.23) | 78 (6) | 286 (22) |
7 and above drugs | 2 (0.15) | 8 (0.62) | 4 (0.31) | 14 (1.08) | 28 (2.15) |
Total | 350 (26.92) | 355 (27.31) | 355 (27.31) | 240 (18.46) | 1300 (100) |
Mean ± S.D | 2.99 ± 1.193 | 2.43 ± 1.096 | 2.94 ± 1.3 | 3.10 ± 1.765 | 2.85 ± 1.358 |
Range | 6 (2–8) | 7 (1–8) | 7 (1–8) | 8 (1–9) | 8 (1–9) |
Hospital stay | |||||
1 to 5 days | 331 (25.46) | 317 (24.38) | 311 (23.92) | 175 (13.46) | 1134 (87.23) |
6 to 10 days | 19 (1.46) | 32 (2.46) | 44 (3.38) | 46 (3.54) | 141 (10.85) |
11 or more days | – | 6 (0.46) | – | 19 (1.46) | 25 (1.92) |
Total | 350 (26.92) | 355 (27.31) | 355 (27.31) | 240 (18.46) | 1300 (100) |
Mean ± S.D | 2.14 ± 1.395 | 2.43 ± 1.096 | 3.50 ± 1.606 | 4.60 ± 4.882 | 3.15 ± 2.800 |
Range | 7 (1–8) | 16 (1–17) | 9 (1–10) | 34 (1–35) | 34 (1–35) |
Patients received at least one unlicensed drug | |||||
Y | 254 (19.54) | 290 (22.31) | 252 (19.38) | 205 (15.77) | 1001 (77) |
N | 96 (7.38) | 65 (5.00) | 103 (7.92) | 35 (2.69) | 299 (23) |
Total | 350 (26.92) | 355 (27.31) | 355 (27.31) | 240 (18.46) | 1300 (100) |
Patients received at least one off label drug | |||||
Y | 320 (24.62) | 294 (22.62) | 252 (19.38) | 150 (11.54) | 1016 (78.15) |
N | 30 (2.31) | 61 (4.69) | 103 (7.92) | 90 (6.92) | 284 (21.85) |
Total | 350 (26.92) | 355 (27.31) | 355 (27.31) | 240 (18.46) | 1300 (100) |